Palo Alto, CA (PRWEB) September 23, 2013
Based on data compiled from results of many targeted re-sequencing and exome experiments, users can search using gene symbols, synonyms and gene descriptions giving a visual display of coverage of specific target regions. In addition to providing coverage data, mSeq(TM) reports in a handy summary view of searched gene regions.
Features and Benefits
- Visual display of real of target region coverage, with resolution to single nucleotide positions. Users can quickly understand how completely genes of interest are covered.
- Displays both real coverage and “sequenceable” coverage. Based on real data, users can see if gene regions are difficult to sequence.
- Search input has auto-completion functionality based on gene symbols, synonyms or even gene descriptions. Allows customers to quickly gain information about genes with minimal or incomplete input information.
- Handy summary view for all genes. Researchers can plan effectively before capture and sequencing by seeing how completely genomic regions of interest will be covered.
"Centrillion is committed to next generation sequencing and genomics services for our growing customer base. The launch of mSeq(TM) is an example of our continued effort to provide superior genome, exome and custom targeted next generation sequencing services and useful tools making these technologies accessible to a wider group of customers,” said Wei Zhou, Centrillion’s President and CEO.
mSeq Cloud Version can be accessed at Centrillion Genomic Services' website. mSeq Android Version can be downloaded from Google Play.
About Centrillion Biosciences Inc.
Centrillion Biosciences is a leading genomic and bioinformatics solution provider. Our genomic technology dramatically improves sequencing performance and is compatible with leading genomic technology platforms. With the highest customer return and referral rate, our genomic and bioinformatics services utilize leading technologies and beyond to deliver the highest quality data in the fastest sample to result time. Our world class genomic technology development expertise enables our customers to succeed in the most challenging genomic research projects.
Centrillion Biosciences, Inc.
Read the full story at http://www.prweb.com/releases/2013/9/prweb11142250.htm.
Related medicine news :1
Copyright©2012 Vocus, Inc.
All rights reserved
. NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation2
. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement3
. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children4
. Mayo Clinic launches whole genome breast cancer study5
. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC6
. UCLA launches first face transplantation program in western US7
. Georgia Tech launches HomeLab to help companies evaluate home health technologies8
. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys9
. K9 CarFence™ Launches as Newest Innovation in Pet Transportation10
. Golden Gate Opportunity: Moravia Worldwide Launches Bay Area Operation11
. 'Music Makes It Better' Campaign Launches with Justin Bieber, Victoria Justice, and The Band Perry